Megsan Labs Private Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- 3-31/33, Plot No. 33, Part Sy. No. S - 123, 124, 125 & 142, Kompally, Quthbullapur, Hyderabad, Telangana 500014, India (IND)
- Operations here
- analysis
- FDA identifiers
- FEI 3010960741 · DUNS 650801215
Recent inspection flagged official action
FDA classified an inspection here as OAI (official action indicated) within the last two years — the strongest public warning signal a facility gets. This plant is listed on labels for 2 drugs. A supply problem here can ripple to all of them.
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- OAIDrug Quality Assurance2025-08-22
- VAIDrug Quality Assurance2022-09-23
- OAIDrug Quality Assurance2019-11-01
- VAIDrug Quality Assurance2016-07-15
Drugs this plant is listed as making
2 distinct drugs across 2 products name this site in their FDA label.
- AlcoholBreckenridge Pharmaceutical Inc
- Tafenoquine60 Degrees Pharmaceuticals, INC.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.